Eriacta is a prescription medication containing sildenafil citrate, a potent phosphodiesterase type 5 (PDE5) inhibitor clinically proven to manage erectile dysfunction. It facilitates increased blood flow to the penile tissue upon sexual stimulation, enabling the achievement and maintenance of an erection suitable for satisfactory sexual activity. This medication is intended for adult males and requires a proper medical diagnosis and prescription.

Features

• Active ingredient: Sildenafil Citrate 100mg
• Pharmaceutical form: Film-coated tablets
• Rapid onset of action, typically within 30–60 minutes
• Duration of effect: Up to 4–6 hours
• Requires sexual stimulation for efficacy
• Manufactured under strict GMP guidelines

Benefits

• Clinically proven efficacy in treating erectile dysfunction
• Enables reliable achievement and maintenance of erections
• Supports improved sexual confidence and relationship satisfaction
• Flexible timing due to rapid onset and sufficient duration window
• Non-hormonal mechanism of action with predictable pharmacokinetics
• Well-established safety profile with extensive clinical data

Common use

Eriacta is prescribed for the treatment of erectile dysfunction (ED) in adult males. It is used to facilitate the achievement and maintenance of an erection sufficient for sexual intercourse. The medication is not indicated for use by women, children, or adolescents. It does not protect against sexually transmitted diseases and should not be used recreationally without medical supervision.

Dosage and direction

The recommended starting dose is 50mg taken approximately one hour before anticipated sexual activity. Based on efficacy and tolerability, the dose may be increased to 100mg or decreased to 25mg. The maximum recommended dosing frequency is once per 24-hour period. Tablets should be swallowed whole with a glass of water; administration with a high-fat meal may delay absorption. Do not crush or chew tablets.

Precautions

Prior to initiation, cardiovascular status should be assessed as sexual activity carries potential cardiac risk. Use caution in patients with anatomical penile deformation, predisposition to priapism, or bleeding disorders. Monitor patients with severe renal impairment (creatinine clearance <30 mL/min) or hepatic impairment (Child-Pugh class C). Not recommended for use with other ED treatments. Avoid excessive alcohol consumption during treatment.

Contraindications

Concomitant use with organic nitrates in any form. Hypersensitivity to sildenafil or any excipients. Concurrent administration with guanylate cyclase stimulators. Patients with hereditary degenerative retinal disorders. History of non-arteritic anterior ischemic optic neuropathy (NAION). Severe cardiovascular disorders where sexual activity is inadvisable.

Possible side effects

Common adverse reactions include headache, flushing, dyspepsia, nasal congestion, and visual disturbances (including altered color perception). Less frequently reported effects include dizziness, rash, gastrointestinal discomfort, and myalgia. Rare but serious adverse events include priapism, sudden hearing loss, and cardiovascular events. Discontinue use and seek immediate medical attention for erections lasting more than 4 hours.

Drug interaction

Contraindicated with nitrates and nitric oxide donors. Potentiates hypotensive effects with alpha-blockers (requires careful titration). CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) may increase sildenafil concentrations. Inducers of CYP3A4 may decrease efficacy. Caution with other antihypertensives. Potential interaction with grapefruit juice. Inform your physician of all concomitant medications.

Missed dose

Eriacta is taken on an as-needed basis rather than a scheduled regimen. No missed dose protocol applies. Do not take extra tablets to compensate for a missed dose. Maintain the recommended minimum 24-hour interval between doses.

Overdose

Symptoms may include severe headache, visual disturbances, hypotension, syncope, and prolonged erection. In case of suspected overdose, seek immediate medical attention. Standard supportive measures should be employed; hemodialysis not expected to enhance elimination. Priapism requires urgent urological intervention to prevent tissue damage.

Storage

Store at room temperature (15–30°C) in original packaging. Protect from light and moisture. Keep out of reach of children and pets. Do not use after expiration date. Do not transfer tablets to alternative containers as this may compromise stability.

Disclaimer

This information is for educational purposes only and does not replace professional medical advice. Eriacta is a prescription medication requiring proper medical supervision. Consult a healthcare provider for diagnosis and treatment recommendations. Individual results may vary based on underlying health conditions and adherence to prescribing information.

Reviews

Clinical studies demonstrate significant improvement in erectile function scores compared to placebo. Patient reports indicate high satisfaction rates with onset time and duration of effect. Some users note the importance of proper dosing timing relative to meals. Medical professionals emphasize the necessity of proper patient selection and cardiovascular assessment prior to prescription. Long-term safety data support continued use under medical supervision.